Assessment of dose contribution to pelvic lymph nodes in patients undergoing brachytherapy for carcinoma cervix

Assessment of dose contribution to pelvic lymph nodes in patients undergoing brachytherapy for carcinoma cervix

Background: The inclusion of pelvic lymph node (PLN) metastasis in the FIGO staging system has impacted disease classification and patient survival. Brachytherapy is a key component in managing carcinoma cervix; however, the dose contribution of brachytherapy to PLNs remains unclear. Aims and Obj...

Full description

Saved in:

Bibliographic Details
Main Authors:	Deepak Sharma, Amrut S Kadam, Ramashish Kumar, Raghavendra BK, Srihari G, Perpetua Shruthi A, Varun Chandra
Format:	Article
Language:	English
Published:	Manipal College of Medical Sciences, Pokhara 2024-12-01
Series:	Asian Journal of Medical Sciences
Subjects:	brachytherapy; mean absolute dose; pelvic lymph nodes; carcinoma cervix
Online Access:	https://www.nepjol.info/index.php/AJMS/article/view/69957
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dosimetric Comparison of Inverse Planning Simulated Annealing and Manual Optimization for Intracavitary Cervix Brachytherapy
by: Gökçen İnan, et al.
Published: (2024-02-01)

Clinical Implication of Lateral Pelvic Lymph Node Metastasis in Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
by: In Ja Park
Published: (2022-01-01)

Morphometric parameters of pelvic lymph nodes in experimental metastatic prostate cancer
by: V. V. Astashov, et al.
Published: (2023-06-01)

A review of whole gland prostate brachytherapy with focal dose escalation to intra-prostatic lesions: Clinical efficacy and technical aspects
by: Joel Poder, et al.
Published: (2024-10-01)

In vivo dosimetry with an inorganic scintillation detector during multi-channel vaginal cylinder pulsed dose-rate brachytherapy: Dosimetry for pulsed dose-rate brachytherapy
by: Peter D. Georgi, et al.
Published: (2024-10-01)

Post‐operative incidence of lymphedema after RARP with or without extended pelvic lymph node dissection in a cohort study
by: Andries Clinckaert, et al.
Published: (2025-01-01)

Congenital double cervix abnormality in a heifer
by: Mustafa Sönmez, et al.

Effectiveness, toxicity and impact on quality of life of high-dose-rate brachytherapy delivered in two fractions as monotherapy in patients with prostate cancer
by: Johan Staby Olsén, et al.
Published: (2025-03-01)

Radiant advances: The future of brachytherapy in oral oncology
by: Shyamaladevi Babu, et al.
Published: (2024-12-01)

Proof-of-concept of real-time electromagnetic guidance for gynecologic interstitial catheters in high dose rate brachytherapy
by: Audrey Cantin, et al.
Published: (2024-10-01)

Evaluation of deep learning-based target auto-segmentation for Magnetic Resonance Imaging-guided cervix brachytherapy
by: Rita Simões, et al.
Published: (2024-10-01)

Risk factors for lymphatic leakage following radical cystectomy and pelvic lymph node dissection in patients with muscle-invasive bladder cancer
by: Zixuan Xue, et al.
Published: (2025-01-01)

Polypoid Endometriosis of Cervix: A Case Report
by: Syed Asif Hashmi, et al.
Published: (2023-03-01)

Risk factors for lateral pelvic lymph node metastasis in patients with rectal neuroendocrine tumors: a systematic review and meta-analysis
by: Ziyue Chen, et al.
Published: (2025-01-01)

Risk factors for pelvic lymph node metastasis in cervical cancer: a retrospective analysis of 186 patients
by: Xingyu Sun, et al.
Published: (2025-01-01)

Outcomes of patients with localized prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy boost: A single-center retrospective study
by: Rothwell David, et al.
Published: (2024-06-01)

Primary Lymphoma of Cervix
by: Ji Eun Shim, et al.
Published: (2021-04-01)

Associations of dose to the urethra and long-term patient-reported outcomes after radiotherapy with EBRT and HDR brachytherapy boost for prostate cancer
by: Lars Haack, et al.
Published: (2025-03-01)

Predicting Urinary Function Outcomes Following Low-dose-rate Brachytherapy for Prostate Cancer
by: Gianni Rüedi, et al.
Published: (2025-01-01)

Impact of MRI-based planning in transperineal interstitial brachytherapy for vaginal-involving tumors
by: Diana Guevara Barrera, et al.
Published: (2024-10-01)

PROSPECTS OF APPLICATION OF ORIGINAL MULTIROBOTIC SYSTEM FOR BRACHYTHERAPY OF PROSTATE CANCER
by: N. A. Gryaznov, et al.
Published: (2017-02-01)

In-depth feasibility study on conservative surgery, perioperative high-dose-rate brachytherapy, and external beam radiation therapy, with a focus on interstitial brachytherapy for soft tissue sarcomas: Insights from a single-institute experience
by: Purnima Thakur, et al.
Published: (2024-10-01)

Access to brachytherapy treatment for cervical cancer management in Africa
by: Emmanuel Fiagbedzi, et al.
Published: (2025-01-01)

Assessment of uterine caruncles, uterine cervix, and vulva during the postpartum period in Kivircik ewes with shear-wave elastography
by: Zeynep Günay Uçmak, et al.
Published: (2024-12-01)

Brachytherapy as a treatment of a vasoproliferative retinal tumor
by: Andrei A. Yarovoy, et al.
Published: (2022-07-01)

Artificial intelligence in high-dose-rate brachytherapy treatment planning for cervical cancer: a review
by: Junyue Shi, et al.
Published: (2025-01-01)

Inferior oblique sparing brachytherapy plaque placement for juxtafoveal peripapillary choroidal melanoma
by: Neiwete Lomi, et al.
Published: (2025-02-01)

Comparing the efficacy of tadalafil and tamsulosin for managing erectile dysfunction and lower urinary tract symptoms in prostate brachytherapy patients: a prospective study
by: Nozomi Hayakawa, et al.
Published: (2024-12-01)

Comparative Study of Cervical Pap Smear and Visual Inspection of The Cervix To Detect Premalignant Disease of The Cervix
by: Rozhan Yassin Khalil, et al.
Published: (2020-06-01)

Surface mold brachytherapy for head and neck non-melanoma skin cancer – local control rates and survival: A retrospective analysis
by: Ebrahim Esmati, et al.
Published: (2024-10-01)

Long-term outcomes of LDR-brachytherapy for localized prostate cancer
by: Lauri Mäkelä, et al.
Published: (2025-01-01)

An Incidentally Detected Venous Malformation of the Uterine Cervix: Case Report
by: Yeşim Bayoğlu Tekin, et al.
Published: (2015-12-01)

Yttrium-90 (90Y) brachytherapy for squamous carcinoma: Treatment of the conjunctiva, cornea, and sclera
by: Arpita Maniar, et al.
Published: (2024-12-01)

Development and international multicentre pilot testing of a postal dosimetry audit methodology for high dose rate brachytherapy
by: Alexis Dimitriadis, et al.
Published: (2024-10-01)

Where are we with fractionation schedules and prescriptions in high-dose-rate 3D planning vaginal cuff brachytherapy?
by: Angeles Rovirosa, et al.
Published: (2024-10-01)

Dwell time shaping in inverse treatment planning for cervical brachytherapy
by: Frida Dohlmar, et al.
Published: (2024-10-01)

Relationship between endometriosis and uterine cervical elasticity assessed using ultrasound strain elastography
by: Anjeza Xholli, et al.
Published: (2024-11-01)

Two cases of mixed large cell neuroendocrine carcinoma and adenocarcinoma of the cervix: case report and review of the literature
by: Kang-Na Wei, et al.
Published: (2024-12-01)

Hydrogen‐Generating Magnesium Alloy Seed Strand Sensitizes Solid Tumors to Iodine‐125 Brachytherapy
by: Pan Hu, et al.
Published: (2025-02-01)

The clinical value of Delphian and pre-tracheal lymph nodes in predicting lateral lymph nodes metastasis of papillary thyroid carcinoma
by: Chun Huang, et al.
Published: (2025-12-01)